Calcium Intake Linked to Reduced Colorectal Cancer Risk, Study Finds
Kansas City’s TB Outbreak Can Be Contained With the Lessons From COVID-19
Powles Highlights “Transformative” Benefit of EV Plus Pembro While Sharing Long-Term Data for EV-302
Analysis Looks at Benefits, Toxicity of ADC Combinations in Advanced Bladder Cancer
Adults With DMD More Than Twice as Likely to Experience Fractures
TROPION-Breast01: Datopotamab Deruxtecan Improves Progression-Free Survival
What Drives Health Care Spending Differences Across US Counties?
Mitigating Barriers to Cell and Gene Therapy Access
ACS’ Dahut on Finding Cancer Before It Starts, and Funding Researchers as They Start
The Impact of ADT for Prostate Cancer on Survival and Patient Well-Being
5 Things That Impact Heart Health
Findings Suggest Potential Link Between Overactive Bladder, Osteoarthritis
Bimekizumab for Hidradenitis Suppurativa Offers Durable Disease Control in Long-Term Data
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD
Adults With Depression Likely Develop Physical Conditions 30% Faster
Oral Roflumilast Shows Promise for Moderate to Severe Psoriasis
ASCO GU Posters Address Cost-Effectiveness, Implementation Barriers for New mUC Treatments
TILs May Guide Treatment De-Escalation in ERBB2-Positive Breast Cancer
Robert F. Kennedy Jr Confirmed as HHS Secretary, Nearly Along Party Lines
Abortion Bans Linked to Higher Infant Mortality, Disproportionately Impact Black Infants
Rapid IV Isatuximab Could Shift Care Practices in MM
Cuts to PEPFAR Spell Detrimental HIV Outcomes in South Africa
Understanding TB Symptoms, Spread, Treatment Amid Kansas City Outbreak
Risdiplam Tablet for Spinal Muscular Atrophy Receives FDA Approval
Evaluation System Reduces Ineffective Hospital Days in Colorectal Cancer Care
High Prevalence of Sarcopenia Identified in Patients With Ovarian, Endometrial Cancer
Systemic Solutions to Improve Telehealth Access for Non-English Speakers
Despite Increases, Gender Disparities in Life Expectancy Persist Among People With HIV
FDA Approves Mirdametinib for Neurofibromatosis Type 1 With Plexiform Neurofibromas
FDA Approves Brentuximab Vedotin, Lenalidomide, Rituximab Triplet for R/R LBCL